Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK consumer products stolen

This article was originally published in The Tan Sheet

Executive Summary

Multiple cases of GlaxoSmithKline OTC products and Rx drugs were stolen Jan. 29 while being transported from a distributor to wholesalers in the Bayamon district of Puerto Rico, FDA and GSK say in a Feb. 24 release. Stolen consumer products include full cases of Tums antacid, Sensodyne toothpaste, Poligrip denture adhesive and Ecotrin aspirin. This is not the first time GSK was victimized. Thieves also stole a tractor trailer filled with OTC products from the firm last November and before that they stole two lots of Advair Diskus from a distribution facility last August. GSK and FDA are looking for the stolen products, and the manufacturer warns consumers not to use products with tampered or damaged packaging

You may also be interested in...



FDA cargo thief warning

In an April 28 letter, FDA directs manufacturers, wholesalers and retailers to "immediately review their in-transit and warehouse security practices" to prevent cargo theft - an increasing industry problem (1"The Tan Sheet" March 1, 2010). Firms should proactively plan a response to a theft "since swift action is essential" to protect the public, the agency said. It explained stolen products can cause adverse events if stored or handled improperly. If products are stolen, firms should promptly notify FDA's Office of Criminal Investigations and the public. In some cases firms will need to recall products with the same lot numbers as the stolen products, FDA said. The agency typically will ask the firm for details about the stolen product, a risk assessment and an action plan

Naturopath Marketing Brain Defense Supplement Anticipates Support For Making TBI Claims

Cover Three Nutritional Brain Defense marketer agrees to pull claims suggesting the supplement beverage can protect against traumatic brain injury after a test the firm on DHA submitted as support contained considerably higher levels of the ingredient than included in the product.

Alnylam Shows Efficacy, Safety With Lumasiran In Vulnerable Pediatric Patients

The top-line data in the ultra-rare disease are also the first to demonstrate safety and efficacy of an RNAi therapy in patients six years and younger.

Topics

UsernamePublicRestriction

Register

ID1132115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel